Galvez, Esmin M.

HRN: 24-81-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2026
CEFTRIAXONE 1G (VIAL)
08/05/2026
08/11/2026
IV
2g
OD
Abrasions, Fracture
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: